rosiglitazone has been researched along with 3-nitrotyrosine in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (84.62) | 29.6817 |
2010's | 2 (15.38) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caputi, AP; Chatterjee, PK; Cuzzocrea, S; Di Paola, R; Di Rosa, M; Dugo, L; Genovese, T; Ianaro, A; Patel, NS; Pisano, B; Thiemermann, C | 1 |
Batinic-Haberle, I; Christopher, TA; Gao, E; Liu, HR; Lopez, BL; Ma, XL; Ohlstein, EH; Tao, L; Teng, ZP; Willette, RN; Yue, TL | 1 |
Britti, D; Caputi, AP; Cuzzocrea, S; De Maio, M; Di Paola, R; Dugo, L; Genovese, T; Mazzon, E; Patel, NS; Serraino, I; Thiemermann, C | 1 |
Caputi, AP; Catalano, P; Crimi, N; Cuzzocrea, S; Di Paola, R; Genovese, T; Mastruzzo, C; Mazzon, E; Sortino, M; Thiemermann, C; Vancheri, C | 1 |
Geng, ZL; Liu, D; Wang, YL; Zeng, BX; Zeng, L; Zhang, SF; Zhang, SH | 1 |
Bhatia, M | 1 |
Britti, D; Cuzzocrea, S; De Majo, M; Di Paola, R; Genovese, T; Maiere, D; Mazzon, E; Zito, D | 1 |
Díaz-Sanjuán, T; García-Ruiz, I; Martínez, MA; Muñoz-Yagüe, T; Rodríguez-Juan, C; Solís-Herruzo, JA | 1 |
Ayaz, L; Emre, M; Günay, I; Inal, T; Kavak, S; Tamer, L | 1 |
Bierhaus, A; Bozorgmehr, F; Dugi, K; Hamann, A; Humpert, PM; Ibrahim, Y; Kientsch-Engels, R; Kukudov, G; Morcos, M; Nawroth, PP; Oikomonou, D; Pfisterer, F; Rudofsky, G; Sayed, AA; Schlotterer, A; Schneider, J; Schwenger, V; van der Woude, F; Yard, B; Zeier, M | 1 |
Bajirovic, V; Byun, J; Kellogg, A; Oral, E; Pennathur, S; Pop-Busui, R; Raffel, D; Stevens, MJ; Vivekanandan-Giri, A | 1 |
Aggarwal, S; Azakie, A; Black, SM; Datar, SA; Fineman, JR; Fratz, S; Hsu, JH; Kumar, S; Lu, Q; Oishi, PE; Raff, G; Sajti, E; Sharma, S | 1 |
Gaekens, M; Gallacher, DJ; Hemmeryckx, B; Lijnen, HR; Lu, HR | 1 |
1 trial(s) available for rosiglitazone and 3-nitrotyrosine
Article | Year |
---|---|
Impact of rosiglitazone and glyburide on nitrosative stress and myocardial blood flow regulation in type 2 diabetes mellitus.
Topics: Adiponectin; Adult; Blood Glucose; C-Reactive Protein; Cohort Studies; Coronary Vessels; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipid Metabolism; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Reactive Nitrogen Species; Rosiglitazone; Thiazolidinediones; Tyrosine; von Willebrand Factor | 2009 |
12 other study(ies) available for rosiglitazone and 3-nitrotyrosine
Article | Year |
---|---|
Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
Topics: Animals; Benzhydryl Compounds; Blood Pressure; Epoxy Compounds; Immunologic Factors; Intercellular Adhesion Molecule-1; Interleukin-1; Intestinal Mucosa; Intestines; Ligands; Male; Malondialdehyde; Peroxidase; Prostaglandin D2; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Reperfusion Injury; Rosiglitazone; Thiazolidinediones; Transcription Factors; Tumor Necrosis Factor-alpha; Tyrosine; Vasodilator Agents | 2003 |
Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-gamma agonist in hypercholesterolemia.
Topics: Animals; Antioxidants; Blood Vessels; Carotid Arteries; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Disease Models, Animal; Hypercholesterolemia; In Vitro Techniques; Lipids; Male; Nitrates; Nitric Oxide; Nitrites; Rabbits; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcription Factors; Tyrosine; Vasodilation | 2003 |
Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma.
Topics: Animals; Arthritis, Experimental; Collagen Type II; Cyclooxygenase 2; Interleukin-1; Interleukin-6; Isoenzymes; Joints; Lipid Peroxidation; Mice; Mice, Inbred DBA; Neutrophils; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Poly(ADP-ribose) Polymerases; Prostaglandin-Endoperoxide Synthases; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors; Tumor Necrosis Factor-alpha; Tyrosine; Vasodilator Agents | 2003 |
Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury.
Topics: Analysis of Variance; Animals; Benzhydryl Compounds; Biopsy; Bleomycin; Epoxy Compounds; Immunoenzyme Techniques; Instillation, Drug; Male; Mice; Nitric Oxide Synthase; Peroxidase; Poly(ADP-ribose) Polymerases; Prostaglandin D2; Pulmonary Fibrosis; Random Allocation; Rosiglitazone; Thiazolidinediones; Tyrosine; Weight Loss | 2005 |
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, reduces acute lung injury in endotoxemic rats.
Topics: Anilides; Animals; Endotoxemia; Lipopolysaccharides; Lung; Male; Nitric Oxide; Nitric Oxide Synthase Type II; PPAR gamma; Rats; Rats, Wistar; Respiratory Distress Syndrome; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Tyrosine | 2005 |
Peroxisome proliferator-activated receptor-gamma ligands protect against lung injury: potential therapeutic targets?
Topics: Animals; Humans; Lung; Nitric Oxide; Nitric Oxide Synthase Type II; PPAR gamma; Rats; Respiratory Distress Syndrome; Rosiglitazone; Thiazolidinediones; Tyrosine | 2005 |
Rosiglitazone reduces the evolution of experimental periodontitis in the rat.
Topics: Alveolar Bone Loss; Animals; Anti-Inflammatory Agents, Non-Steroidal; Ligation; Male; Neutrophil Infiltration; Nitric Oxide Synthase Type II; Periodontitis; Poly(ADP-ribose) Polymerase Inhibitors; PPAR gamma; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Rosiglitazone; Thiazolidinediones; Tyrosine | 2006 |
Effects of rosiglitazone on the liver histology and mitochondrial function in ob/ob mice.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Body Weight; Fatty Liver; Lipid Peroxidation; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Microscopy, Electron; Mitochondria, Liver; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tyrosine | 2007 |
The effects of rosiglitazone on oxidative stress and lipid profile in left ventricular muscles of diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Glycated Hemoglobin; Heart Ventricles; Lipid Metabolism; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Rosiglitazone; Streptozocin; Thiazolidinediones; Tyrosine | 2008 |
Rosiglitazone reduces angiotensin II and advanced glycation end product-dependent sustained nuclear factor-kappaB activation in cultured human proximal tubular epithelial cells.
Topics: Angiotensin II; Cell Nucleus; Cells, Cultured; Diabetic Nephropathies; Epithelial Cells; Gene Expression; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Kidney Tubules, Proximal; NF-kappa B; Oxidative Stress; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Rosiglitazone; Thiazolidinediones; Tyrosine | 2008 |
Rosiglitazone preserves pulmonary vascular function in lambs with increased pulmonary blood flow.
Topics: Acetylcholine; Analysis of Variance; Animals; Animals, Newborn; Blotting, Western; Hemodynamics; NADPH Oxidases; Nitric Oxide; PPAR gamma; Pulmonary Circulation; Pulmonary Wedge Pressure; rac1 GTP-Binding Protein; Rosiglitazone; Sheep; Superoxide Dismutase; Thiazolidinediones; Tyrosine; Vascular Resistance | 2013 |
Effect of rosiglitazone on liver structure and function in genetically diabetic Akita mice.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Cholesterol, Dietary; Diabetes Mellitus; Diet, High-Fat; Fatty Liver; Gene Expression; Genotype; Liver; Male; Mice; Mice, Inbred C57BL; Organ Size; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Triglycerides; Tyrosine | 2013 |